Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs

被引:66
|
作者
Beloqui, Ana [1 ]
del Pozo-Rodriguez, Ana [2 ]
Isla, Arantxazu [2 ]
Rodriguez-Gascon, Alicia [2 ]
Angeles Solinis, Maria [2 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
[2] Univ Basque Country, Pharmacokinet Nanotechnol & Gene Therapy Grp Phar, Fac Pharm, UPV EHU,Lascaray Res Ctr, Paseo Univ 7, Vitoria 01006, Spain
关键词
Nanostructured lipid carriers; Poor water soluble drugs; Oral drug delivery; Bioavailability; Hot high-pressure homogenization; Inflammatory bowel diseases; OF-THE-ART; BIOAVAILABILITY ENHANCEMENT; IN-VIVO; PHYSICOCHEMICAL CHARACTERIZATION; FORMULATION DEVELOPMENT; GASTROINTESTINAL MUCUS; INTESTINAL BARRIER; NANOPARTICLES SLN; LIPOPHILIC DRUGS; PHARMACOKINETICS;
D O I
10.1016/j.jddst.2017.06.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poorly water soluble (PWS) drugs lack from good oral absorption, which limits their oral administration, the most common drug delivery route. The design of appropriate innovative formulations for PWS drugs will allow for adequate bioavailability, reduction of the required dose and oral delivery of drugs that would otherwise need the parenteral route. Among the formulations under study, Nanostructured Lipid Carriers (NLCs), made of biocompatible mixtures of solid and liquid lipids, represent a good choice. NLCs enhance the apparent solubility and dissolution of PWS drugs in the gastrointestinal tract, and/or modulate the drug permeability and fate across the intestinal barrier, opening new perspectives in the field of innovative medicines for oral administration of PWS molecules. Recently, NLCs have also emerged as a promising anti-inflammatory drug delivery system for inflammatory bowel diseases. The present paper is focused on the state of the art of NLCs for oral delivery of PWS drugs. The design, the main preparation techniques and the mechanisms through the drug oral delivery is improved by NLCs are presented, highlighting the influence of the most relevant technological and formulation factors on the properties of the NLCs, which condition their efficacy as oral delivery formulations. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 50 条
  • [41] Ocular delivery systems for poorly soluble drugs: An in-vivo evaluation
    Luschmann, C.
    Herrmann, W.
    Strauss, O.
    Luschmann, K.
    Goepferich, A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 455 (1-2) : 331 - 337
  • [42] Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
    Khan, Saba
    Baboota, Sanjula
    Ali, Javed
    Khan, Sana
    Narang, Ramandeep Singh
    Narang, Jasjeet Kaur
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2015, 5 (04) : 182 - 191
  • [43] Novel nanogels as drug delivery systems for poorly soluble anticancer drugs
    Li, Na
    Wang, Jinli
    Yang, Xingguo
    Li, Lingbing
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 83 (02) : 237 - 244
  • [44] Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
    Boyd, Ben J.
    Bergstrom, Christel A. S.
    Vinarov, Zahari
    Kuentz, Martin
    Brouwers, Joachim
    Augustijns, Patrick
    Brandl, Martin
    Bernkop-Schnuerch, Andreas
    Shrestha, Neha
    Preat, Veronique
    Mullertz, Anette
    Bauer-Brandl, Annette
    Jannin, Vincent
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 137
  • [45] Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs
    Efentakis, M.
    Naseef, H.
    Vlachou, M.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (08) : 903 - 916
  • [46] Gastrointestinal lipolysis of lipid-based excipients intended for the oral drug delivery of poorly water-soluble drugs
    Fernandez, Sylvie
    Carriere, Frederic
    Jannin, Vincent
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2010, 17 (04) : 259 - 263
  • [47] Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs
    Yasmin, Rokhsana
    Rao, Shasha
    Bremmell, Kristen
    Prestidge, Clive
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 96 : 508 - 514
  • [48] Lipid-Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs
    Roohi Kesharwani
    Pankaj Jaiswal
    Dilip Kumar Patel
    Pankaj Kumar Yadav
    Biomedical Materials & Devices, 2023, 1 (2): : 648 - 663
  • [49] Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water-Soluble Drugs: Peroral and Mucosal Routes
    Silva, A. C.
    Santos, D.
    Ferreira, D.
    Lopes, C. M.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (26) : 4495 - 4510
  • [50] Nanostructured Lipid Carriers for Oral Delivery of a Corticosteroid: Role of Formulation on Biopharmaceutical Performance
    Ibrahim, Shaimaa S.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (03) : 790 - 797